Company / Operating Cash Flow per Share
Royalty Pharma plc Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$4.13
FY2025
5-year range
$4.13 / $7.20
FY2021-FY2025
Trend
-34.7%
vs FY2024
Sector context
#27 of 212
Health Care
What the data says
Royalty Pharma plc's operating cash flow per share of $4.13 is higher than 87% of companies in the Health Care sector (FY2025). Declined from $7.20 to $4.13 over the past 2 years.
Based on SEC 10-K filings.
4.13 in FY2025 with a 5-year CAGR of -0.9%. Top quartile in the Health Care sector.
Declined from $7.20 to $4.13 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -8.7%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 212This company $4.13 Sector average $5.28
▼
-21.7% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 34.7% year-over-year.
- Ranks #27 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.13 | -34.7% |
| FY2024 | $6.32 | -12.2% |
| FY2023 | $7.20 | +32.9% |
| FY2022 | $5.42 | +22.0% |
| FY2021 | $4.44 | +3.0% |
| FY2020 | $4.31 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026